Two recent meta-analyses of randomized, placebo-controlled trials found no evidence that coenzyme Q 10 improved motor-related symptoms or delayed the progression of the disease when compared to placebo (68, 69)
BAs are synthesized in hepatocytes predominantly by the classic pathway, which is controlled by 7-hydroxylase (CYP7A1), and to a lesser extent by the mitochondrial alternative pathway, which is determined by the availability of cholesterol in the IMM for its metabolism by sterol 27-hydroxylase (CYP27A1)
Recommended articles The Effects and Pathogenesis of PM2.5 and Its Components on Chronic Obstructive Pulmonary Disease Wang Q, Liu S International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:493-506 Published Date: 6 April 2023 Exercise Prescription Training in Chronic Obstructive Pulmonary Disease: Benefits and Mechanisms Liu S, Yang A, Yu Y, Xu B, Yu G, Wang H International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:1071-1082 Published Date: 15 April 2025 Targeting Senescence, Oxidative Stress, and Inflammation: Quercetin-Based Strategies for Ocular Diseases in Older Adults Medoro A, Davinelli S, Scuderi L, Scuderi G, Scapagnini G, Fragiotta S Clinical Interventions in Aging 2025, 20:791-813 Published Date: 7 June 2025 Bioactive Nanomaterials: Comprehensive Monitoring and Regulation of Acute Pancreatitis Induced Acute Lung Injury Obeng E, Ergashev A, Yao Q, Wu W, Chen G International Journal of Nanomedicine 2025, 20:9517-9558 Published Date: 31 July 2025 Enhancing the Antidepressant Efficacy of Quercetin via Brain-Targeted Lipid Nanocarriers: Fabrication, Characterization, and Evaluation Chen T, Zeng M, Xiong L, Li W, Cheng Z, Wang C International Journal of Nanomedicine 2025, 20:15793-15811 Published Date: 26 December 2025
doi: 10.1111/j.1432-1033.1996.0008u.x
